Cohen Independent Research Group Publishes Nutra Pharma Profile
Oct 28, 2009 (Close-Up Media via COMTEX) --
Company: Nutra Pharma Corp. (NPHC)
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced that Cohen Independent Research Group has published a report profiling Nutra Pharma Corp.
The report, which was commissioned by Nutra Pharma, focuses on the company's current drug development initiatives, including the company's leading drug candidates for the treatment of Multiple Sclerosis (MS), HIV, Adrenomyeloneuropathy (AMN), and Rheumatoid Arthritis (RA) as well as the company's recent launch of Cobroxin for the treatment of chronic pain, the Company noted in a release.
Report Information:
http://www.cohenresearch.com/reports/nphc_10-21-09.pdf
((Comments on this story may be sent to health@closeupmedia.com))
Copyright (C) 2009 Close-Up Media. All rights reserved
News Provided by COMTEX
Company: Nutra Pharma Corp. (NPHC)
Related terms: arthritis, biotechnology, health, hiv, research
